Dirocaftor Uses, Dosage, Side Effects and more
Dirocaftor is under investigation in clinical trial NCT03251092 (Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis).
| Trade Name | Dirocaftor |
| Generic | Dirocaftor |
| Dirocaftor Other Names | Dirocaftor |
| Type | |
| Formula | C22H28N2O3Si2 |
| Weight | Average: 424.647 Monoisotopic: 424.16384584 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
